Charles Schwab Investment Management Inc. Raises Position in HealthEquity, Inc. (NASDAQ:HQY)

Charles Schwab Investment Management Inc. grew its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,086,811 shares of the company's stock after acquiring an additional 25,004 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.25% of HealthEquity worth $104,280,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in HQY. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC raised its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $39,000. UMB Bank n.a. raised its position in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after purchasing an additional 164 shares during the period. Finally, First Horizon Advisors Inc. lifted its stake in HealthEquity by 50.7% during the fourth quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company's stock worth $107,000 after purchasing an additional 375 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective for the company. BTIG Research lifted their target price on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. Royal Bank of Canada increased their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. Barrington Research lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Monday, December 2nd. Finally, Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price on the stock. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of "Moderate Buy" and a consensus target price of $113.54.

Remove Ads

Insider Activity at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company's stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.

HealthEquity Stock Down 6.1 %

Shares of NASDAQ HQY traded down $6.10 during midday trading on Monday, hitting $94.48. 1,018,406 shares of the company's stock were exchanged, compared to its average volume of 649,018. The firm's fifty day simple moving average is $105.80 and its 200-day simple moving average is $94.66. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market cap of $8.19 billion, a PE ratio of 86.68, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the firm posted $0.40 EPS. Research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.